Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

Reference Listed Drug Labeling Supplements Approved in November 2001

Click on appropriate hyperlink below to view available source document in PDF format.

Approval Date

Trade Name

  

Active Ingredient(s)/Dosage Form

NDA No.

Supp. No.

Nov 1 COREG letter      carvedilol tablets 20-297 S-007
INDERIDE LA letter label propranolol HCl/HCTZ extended-release capsules 19-059 S-016
INDERIDE letter label propranolol HCl/HCTZ tablets 18-031 S-030
Nov 5

TAMIFLU

letter

label

oseltamivir phosphate suspension

oseltamivir phosphate capsules

21-246

21-087

S-004

S-009

Nov 7

REGLAN

letter

label

metoclopramide HCl solution

metoclopramide HCl tablet

metoclopramide HCl injection

18-821

17-854

17-862

S-020

S-041

S-048

Nov 9 MYCOBUTIN letter label rifabutin capsules 50-689 S-013

Nov 14

LUPRON DEPOT

letter

    

leuprolide acetate injectable

20-011

S-022

LUPRON DEPOT-3

letter

    

leuprolide acetate injectable

20-708

S-013

PROSOL 20% SULFITE FREE

letter

    

amino acid injection

20-849

S-004

ZOCOR

letter

label

simvastatin tablet

19-766

S-053

ZOVIRAX

letter

label

acyclovir tablets

acyclovir suspension

acyclovir capsule

20-089

19-909

18-828

S-016

S-017

S-027

Nov 16 CALCIJEX letter      calcitriol injection 18-874 S- 016

VIDEX

letter

label

didanosine tablets

didanosine oral solution

20-155

20-154

S-027

S-036

Nov 20

DILANTIN

DILANTIN-125

letter

     

phenytoin injection

phenytoin suspension

10-151

8-762

S-034

S-026

Nov 21 CLEOCIN PHOSPHATE letter label clindamycin injection 50-441 S-047
ROCEPHIN W/ DEXTROSE letter     ceftriaxone injection 50-624 S-021
Nov 23 SINGULAIR letter label montelukast sodium tablets 20-830 S-011
Nov 26 INAPSINE letter      droperidol injection 16-796 S-039
INDOCIN letter      indomethacin suspension 18-332 S-023
LITHIUM CARBONATE letter      lithium carbonate capsules 17-812 S-017
LITHIUM CITRATE letter      lithium citrate syrup 18-421 S-016

Nov 27

VASERETIC

letter

label

enalapril maleate/HCTZ tablet

19-221

S-026

VASOTEC

letter

letter

label

label

enalaprilat injection

enalapril maleate tablets

19-309

18-998

S-023

S-058

WYTENSIN

letter

    

guanabenz acetate tablets

18-587

S-023

Nov 28 ATACAND letter      candesartan cilexetil tablets 20-838 S-016
ATACAND HCT letter      candesartan cilexetil/HCTZ tablets 21-093 S-001
Nov 30

PRIMAXIN IM

PRIMAXIN IV

letter

label

label

imipenem/cilstatin sodium injection

imipenem/cilstatin sodium injection

50-630

50-587

S-017

S-053

TIMOPTIC letter label timolol maleate ophthalmic solution 18-086 S-056
 totop.gif (1525 bytes)Back to Top   Back Labeling Review Branch Page
FDA/Center for Drug Evaluation and Research
Last Updated: January 18, 2006
Originator: OTCOM/DLIS
HTML by JFG